Rifampicin in Serious Acinetobacter baumannii InfectionRifampicin in Serious Acinetobacter baumannii Infection
Adding rifampicin to colistin does not help patients survive serious infections with extensively drug-resistant (XDR) Acinetobacter baumannii, an Italian phase III study shows. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 29, 2013 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
Protracted Outbreak of MDRAB After Transfer of PatientsProtracted Outbreak of MDRAB After Transfer of Patients
Multidrug-resistant Acinetobacter baumannii is an increasing threat to hospitals. Read how this hospital became infected. Infection Control and Hospital Epidemiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 22, 2013 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news
John Hopkins Researchers Demonstrate Hydrogen Peroxide’s Effectiveness in Preventing HAIs, May Have Use in Clinical Pathology Laboratories
The study found that a Robotic vapor-dispersing device kills and prevents spread of Drug-Resistant Organisms in high-risk patients by 64% There is a new technology for disinfecting healthcare facilities that is likely to be useful for clinical laboratories and anatomic pathology groups. A team at Johns Hopkins University Hospital recently published a study about their [...] (Source: Dark Daily)
Source: Dark Daily - February 6, 2013 Category: Laboratory Medicine Authors: jude Tags: Instruments & Equipment Laboratory News Laboratory Pathology Acinetobacter baumannii anthrax AsepticSure Bioquell BQE C. diff chlorhexidine Clinical Infectious Diseases clinical laboratory Clostridium difficile DarkDaily.com Di Source Type: news
